Jinling Pharmaceutical Company Limited (000919.SZ)
CNY 6.91
(-1.14%)
CNY 6.91
(-1.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 158.92 Million | 260.59 Million | 292.02 Million | 311.46 Million | 465.84 Million | 433.82 Million |
| Net Income | 107.18 Million | 113.86 Million | 152.93 Million | 93.65 Million | 183.67 Million | 288.87 Million |
| Depreciation & Amortization | 131.26 Million | 124.33 Million | 122.95 Million | 119.87 Million | 122.43 Million | 123.28 Million |
| Deferred income taxes | -8.76 Million | -17.76 Million | 129.41 Thousand | -4.87 Million | 8.86 Million | -2.69 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -72.05 Million | 63.6 Million | 11.12 Million | 30.21 Million | 207.07 Million | 169.64 Million |
| Other non-cash items | 7.26 Million | -41.21 Million | 5.01 Million | 67.71 Million | -47.34 Million | -147.97 Million |
| Investing Cash Flow | -370.15 Million | -221.11 Million | -69.12 Million | -377.5 Million | 123.55 Million | -95.31 Million |
| Investments in PPE | -186.25 Million | -309.64 Million | -162.76 Million | -291.4 Million | -125.71 Million | -136.42 Million |
| Acquisitions | 28.12 Million | -21.77 Million | 64.93 Million | 291.92 Million | 156.02 Million | 150.82 Million |
| Investment purchases | -647.96 Million | -293.6 Million | -266.3 Million | -293.92 Million | -248 Million | -786.36 Million |
| Sales/Maturities of investments | 440.43 Million | 323.84 Million | 296.25 Million | 207.31 Million | 466.95 Million | 670.47 Million |
| Other Investing Activities | -183.9 Million | 80.05 Million | -1.24 Million | -291.4 Million | -125.71 Million | 6.17 Million |
| Financing Cash Flow | -43.26 Million | -46.26 Million | -39.64 Million | -89.82 Million | -89.58 Million | -280.44 Million |
| Debt repayment | -1.47 Million | -20.99 Million | -15 Million | - | -660 Thousand | -207.87 Million |
| Dividends payments | -51.15 Million | -50.4 Million | -50.4 Million | -85.68 Million | -85.68 Million | -128.39 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 11.53 Million | 25.89 Million | 26.01 Million | 450 Thousand | -2.89 Million | 55.82 Million |
| Accounts receivables | 71.65 Million | -56.16 Million | -107.93 Million | -110.36 Million | 155.96 Million | -44.24 Million |
| Accounts payables | -117.02 Million | 129.53 Million | 148.96 Million | 125.27 Million | 77.19 Million | 127.15 Million |
| Inventory | -17.91 Million | 7.99 Million | -30.03 Million | 20.17 Million | -34.94 Million | 89.41 Million |
| Other working capital | -125.79 Million | -17.76 Million | 129.41 Thousand | -4.87 Million | 8.86 Million | 80.22 Million |
| Cash at beginning of period | 1.47 Billion | 1.48 Billion | 1.29 Billion | 1.45 Billion | 954.39 Million | 896.32 Million |
| Cash at end of period | 1.22 Billion | 1.47 Billion | 1.48 Billion | 1.29 Billion | 1.45 Billion | 954.39 Million |
| Capital Expenditure | -186.25 Million | -309.64 Million | -162.76 Million | -291.4 Million | -125.71 Million | -136.42 Million |
| Effect of forex changes on cash | 19.01 Thousand | 79.81 Thousand | -1127.23 | 661.98 | -1436.75 | 1158.50 |
| Net cash flow / Change in cash | -254.48 Million | -6.7 Million | 183.25 Million | -155.87 Million | 499.81 Million | 58.07 Million |
| Free Cash Flow | -27.32 Million | -49.05 Million | 129.26 Million | 20.05 Million | 340.13 Million | 297.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.54 Million | 8.27 Million | 43.54 Million | 107.18 Million | 2.04 Million | 20.08 Million |
| Depreciation & Amortization | - | 35.28 Million | 35.28 Million | 131.26 Million | 131.26 Million | -63.27 Million |
| Deferred income taxes | - | - | - | -8.76 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -120.28 Million | - | -72.05 Million | 53.74 Million | 106.45 Million |
| Other non-cash items | -57.44 Million | 130.64 Million | -104.78 Million | 7.26 Million | -20.71 Million | -76.84 Million |
| Investing Cash Flow | -60.79 Million | -460.67 Million | -191.5 Million | -370.15 Million | 149.29 Million | -269.96 Million |
| Investments in PPE | -23.1 Million | -63.31 Million | -25.77 Million | -186.25 Million | -35.92 Million | -64.58 Million |
| Acquisitions | 317.22 Thousand | 458.75 Thousand | 31.3 Thousand | 28.12 Million | 27.86 Million | 21.31 Thousand |
| Investment purchases | -60 Million | -443 Million | -268.8 Million | -647.96 Million | -2.89 Million | -475.06 Million |
| Sales/Maturities of investments | 21.98 Million | 45.18 Million | 103.03 Million | 440.43 Million | 164.75 Million | 269.66 Million |
| Other Investing Activities | 317.22 Thousand | -392.79 Million | -165.73 Million | -183.9 Million | 185.22 Million | 0.07 |
| Financing Cash Flow | -84.34 Thousand | -62.51 Million | 742.61 Million | -43.26 Million | 8.92 Million | -54.06 Million |
| Debt repayment | - | - | - | -1.47 Million | -807.3 Thousand | -5.02 Million |
| Dividends payments | - | -62.17 Million | -21.92 Thousand | -50.4 Million | -50.4 Million | -50.48 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -84.34 Thousand | -62.19 Million | 742.63 Million | 11.53 Million | 9.74 Million | 1.44 Million |
| Accounts receivables | - | -144.27 Million | - | 71.65 Million | 71.65 Million | 119.36 Million |
| Accounts payables | - | - | - | -117.02 Million | - | - |
| Inventory | - | 23.99 Million | - | -17.91 Million | -17.91 Million | -12.9 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.29 Billion | 1.81 Billion | 1.22 Billion | 1.47 Billion | 895.8 Million | 1.23 Billion |
| Cash at end of period | 1.18 Billion | 1.35 Billion | 1.71 Billion | 1.22 Billion | 1.22 Billion | 895.8 Million |
| Capital Expenditure | -23.1 Million | -63.31 Million | -25.77 Million | -186.25 Million | -35.92 Million | -64.58 Million |
| Effect of forex changes on cash | -37.01 Thousand | 36.11 Thousand | 13.3 Thousand | 19.01 Thousand | 44.75 Thousand | -3117.21 |
| Net cash flow / Change in cash | -102.7 Million | -461.65 Million | 489.87 Million | -254.48 Million | 324.59 Million | -337.61 Million |
| Free Cash Flow | -61 Million | 40.31 Million | -87.01 Million | -27.32 Million | 130.4 Million | -78.16 Million |
2930
SJCORP
ECS
LUM
000753
EIHOTEL